Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Inhibition of human endothelial cell proliferation in vitro and neovascularization in vivo by D-penicillamine.
T Matsubara, … , K Hirohata, M Ziff
T Matsubara, … , K Hirohata, M Ziff
Published January 1, 1989
Citation Information: J Clin Invest. 1989;83(1):158-167. https://doi.org/10.1172/JCI113853.
View: Text | PDF
Research Article Article has an altmetric score of 3

Inhibition of human endothelial cell proliferation in vitro and neovascularization in vivo by D-penicillamine.

  • Text
  • PDF
Abstract

To investigate the effects of D-penicillamine (D-Pen) on angiogenesis, we have studied the effects of this drug on in vitro proliferation of human endothelial cells (EC) and in vivo corneal neovascularization. D-Pen, in the presence of copper sulfate, suppressed tritiated thymidine ([3H]TdR) incorporation into EC in a dose-dependent manner. Significant inhibition was observed with D-Pen concentrations attainable in the serum and tissues of treated patients. Neither D-Pen nor copper ion alone significantly affected [3H]TdR incorporation into EC. The inhibition by D-Pen and copper was blocked by catalase (CAT) or horseradish peroxidase but not by boiled CAT or SOD. When rabbits were daily injected intravenously with D-Pen at the per kilogram dosage administered to rheumatoid patients, neovascularization as quantitated by the proliferation of corneal new blood vessels was significantly inhibited. These results suggest that hydrogen peroxide generated by D-Pen and copper exerts a pronounced antiangiogenic effect through inhibition of EC proliferation. It is, therefore, considered that D-Pen may suppress rheumatoid synovitis by reducing the number of small blood vessels available for the emigration of chronic inflammatory cells, and the proliferation of the synovial tissue.

Authors

T Matsubara, R Saura, K Hirohata, M Ziff

×

Total citations by year

Year: 2024 2023 2020 2018 2013 2010 2009 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1975 Total
Citations: 1 1 2 1 2 4 2 4 4 4 1 3 1 4 4 6 5 2 4 8 8 6 8 3 6 1 95
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (95)

Title and authors Publication Year
Using Small Molecules for Targeting Heavy Metals in Neurotoxicity and Neuroinflammation.
Biswas P, More SS
Methods in molecular biology (Clifton, N.J.) 2024
Copper in Gynecological Diseases.
Conforti RA, Delsouc MB, Zorychta E, Telleria CM, Casais M
International journal of molecular sciences 2023
The Multifaceted Roles of Copper in Cancer: A Trace Metal Element with Dysregulated Metabolism, but Also a Target or a Bullet for Therapy
P Lelièvre, L Sancey, JL Coll, A Deniaud, B Busser
Cancers 2020
The combination of disulfiram and copper for cancer treatment
H Li, J Wang, C Wu, L Wang, ZS Chen, W Cui
Drug Discovery Today 2020
Iron and Copper Intracellular Chelation as an Anticancer Drug Strategy
K Gaur, A Vázquez-Salgado, G Duran-Camacho, I Dominguez-Martinez, J Benjamín-Rivera, L Fernández-Vega, LC Sarabia, AC García, F Pérez-Deliz, JM Román, M Vega-Cartagena, S Loza-Rosas, XR Acevedo, A Tinoco
2018
D-penicillamine and other low molecular weight thiols: Review of anticancer effects and related mechanisms
S Wadhwa, RJ Mumper
Cancer Letters 2013
D-Penicillamine for preventing retinopathy of prematurity in preterm infants
MJ Qureshi, M Kumar
Cochrane Database of Systematic Reviews 2013
Angiogenesis
TH Adair, JP Montani
Colloquium Series on Integrated Systems Physiology: From Molecule to Function 2010
Bioinorganic aspects of angiogenesis
LD D'Andrea, A Romanelli, RD Stasi, C Pedone
Dalton Transactions 2010
Turning tumor-promoting copper into an anti-cancer weapon via high-throughput chemistry
F Wang, P Jiao, M Qi, M Frezza, QP Dou, B Yan
Current medicinal chemistry 2010
Intracellular Delivery of the Reactive Oxygen Species Generating Agent d -Penicillamine upon Conjugation to Poly- l -glutamic Acid
S Wadhwa, RJ Mumper
Molecular Pharmaceutics 2010
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 2009
Elevated copper and oxidative stress in cancer cells as a target for cancer treatment
A Gupte, RJ Mumper
Cancer Treatment Reviews 2009
An investigation into copper catalyzed D-penicillamine oxidation and subsequent hydrogen peroxide generation
A Gupte, RJ Mumper
Journal of Inorganic Biochemistry 2007
D-Penicillamine administration and the incidence of retinopathy of prematurity
RD Christensen, SC Alder, SC Richards, DK Lambert, N Schmutz, SE Wiedmeier, J Burnett, VL Baer, JT Horn, M Richards, J Barraza
Journal of Perinatology 2007
Copper chelation by D-penicillamine generates reactive oxygen species that are cytotoxic to human leukemia and breast cancer cells
A Gupte, RJ Mumper
Free radical biology & medicine 2007
Side Effects of Drugs Annual
T Vial, J Descotes, F Braun, M Behrend
Side Effects of Drugs Annual 2007
Effects of combination of melatonin and dexamethasone on acute lung injury in a mice model of carrageenan-induced pleurisy
C Crisafulli, E Mazzon, C Muia, PD Bella, E Esposito, R Meli, S Cuzzocrea
Journal of Pineal Research 2006
Angiostatin generating capacity and anti-tumour effects of D-penicillamine and plasminogen activators
RR de Groot-Besseling, TJ Ruers, IL Lamers-Elemans, CN Maass, RM de Waal, JR Westphal
BMC Cancer 2006
A pilot trial testing the feasibility of administering D-penicillamine to extremely low birth weight neonates
RD Christensen, SC Alder, SC Richards, JT Horn, DK Lambert, VL Baer
Journal of Perinatology 2006
The Cell Cycle in the Central Nervous System
D Janigro
2006
The Role of Copper in Tumour Angiogenesis
SA Lowndes, AL Harris
Journal of Mammary Gland Biology and Neoplasia 2005
Effects of combination M40403 and dexamethasone therapy on joint disease in a rat model of collagen-induced arthritis
S Cuzzocrea, E Mazzon, RD Paola, T Genovese, C Muià, AP Caputi, D Salvemini
Arthritis & Rheumatism 2005
Gene therapy targeting the Tie2 function ameliorates collagen-induced arthritis and protects against bone destruction
Y Chen, E Donnelly, H Kobayashi, LM DeBusk, PC Lin
Arthritis & Rheumatism 2005
Phase 2 trial of copper depletion and penicillamine as antiangiogenesis therapy of glioblastoma
S Brem, SA Grossman, KA Carson, P New, S Phuphanich, JB Alavi, T Mikkelsen, JD Fisher
Neuro-Oncology 2005
A Requirement for Copper in Angiogenesis
ED Harris
Nutrition Reviews 2004
Angiogenesis in Glioma
O Bögler, T Mikkelsen
The Cancer Journal 2003
Molekularmedizinische Grundlagen von rheumatischen Erkrankungen
D Ganten, K Ruckpaul, S Gay, JR Kalden
2003
Physiological electric fields control the G 1 /S phase cell cycle checkpoint to inhibit endothelial cell proliferation
E Wang, Y Yin, M Zhao, JV Forrester, CD McCaig
The FASEB Journal 2003
Inhibition of interleukin-1 but not tumor necrosis factor suppresses neovascularization in rat models of corneal angiogenesis and adjuvant arthritis
A Coxon, B Bolon, J Estrada, S Kaufman, S Scully, A Rattan, D Duryea, YL Hu, K Rex, E Pacheco, G Van, D Zack, U Feige
Arthritis & Rheumatism 2002
Old and New Drugs Used in Rheumatoid Arthritis: A Historical Perspective
JP Case
American Journal of Therapeutics 2001
Angiogenesis in the pathogenesis of inflammatory joint and lung diseases
DA Walsh, CI Pearson
Arthritis research 2001
Head and Neck Cancer
A Forastiere, W Koch, A Trotti, D Sidransky
New England Journal of Medicine 2001
Copper Induces the Assembly of a Multiprotein Aggregate Implicated in the Release of Fibroblast Growth Factor 1 in Response to Stress
M Landriscina, C Bagalá, A Mandinova, R Soldi, I Micucci, S Bellum, I Prudovsky, T Maciag
The Journal of biological chemistry 2001
Angiogenèse : mécanismes généraux et implications au cours de la polyarthrite rhumatoïde
AJ Weber, MD Bandt
Revue du Rhumatisme 2000
Handbook of Oxidants and Antioxidants in Exercise
RR Jenkins, J Beard
Handbook of Oxidants and Antioxidants in Exercise 2000
Effects of combinations of anti‐rheumatic drugs on the production of vascular endothelial growth factor and basic fibroblast growth factor in cultured synoviocytes and patients with rheumatoid arthritis
M Nagashima, K Wauke, D Hirano, S Ishigami, H Aono, M Takai, M Sasano, S Yoshino
Rheumatology (Oxford, England) 2000
Blood Perfusion and Microenvironment of Human Tumors
M Molls, P Vaupel
2000
Tissue inhibition of angiotensin-converting enzyme activity stimulates angiogenesis in vivo
OV Volpert, WF Ward, MW Lingen, L Chesler, DB Solt, MD Johnson, A Molteni, PJ Polverini, NP Bouck
Journal of Clinical Investigation 1999
Inhibitory effects of anti-rheumatic drugs on vascular endothelial growth factor in cultured rheumatoid synovial cells
M Nagashima, S Yoshino, H Aono, M Takai, M Sasano
Clinical & Experimental Immunology 1999
Tissue inhibition of angiotensin-converting enzyme activity stimulates angiogenesis in vivo
OV Volpert, WF Ward, MW Lingen, L Chesler, DB Solt, MD Johnson, A Molteni, PJ Polverini, NP Bouck
Journal of Clinical Investigation 1999
A role for angiogenesis in rheumatoid arthritis
DG Stupack, CM Storgard, DA Cheresh
Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas / Sociedade Brasileira de Biofisica ... [et al.] 1999
Angiogenesis and Cancer Control: From Concept to Therapeutic Trial
S Brem
Cancer control : journal of the Moffitt Cancer Center 1999
Increased transcriptional activity of prostate-specific antigen in the presence of TNP-470, an angiogenesis inhibitor
J Horti, SC Dixon, CJ Logothetis, Y Guo, E Reed, WD Figg
British Journal of Cancer 1999
Angiogenesis: Implications for rheumatoid arthritis
AE Koch
Arthritis & Rheumatism 1998
Quantitative assessment of the rheumatoid synovial microvascular bed by gadolinium-DTPA enhanced magnetic resonance imaging
K Gaffney, J Cookson, S Blades, A Coumbe, D Blake
Annals of the rheumatic diseases 1998
Neomycin inhibits angiogenin-induced angiogenesis
GF Hu
Proceedings of the National Academy of Sciences 1998
Transgenic mice model of ocular neovascularization driven by vascular endothelial growth factor (VEGF) overexpression
L Lakatos
The American Journal of Pathology 1998
Gene Therapy Strategies for Tumor Antiangiogenesis
HL Kong, RG Crystal
JNCI Journal of the National Cancer Institute 1998
The mechanism of cancer-mediated conversion of plasminogen to the angiogenesis inhibitor angiostatin
S Gately, P Twardowski, MS Stack, DL Cundiff, D Grella, FJ Castellino, J Enghild, HC Kwaan, F Lee, RA Kramer, O Volpert, N Bouck, GA Soff
Proceedings of the National Academy of Sciences 1997
The Kinin System
A Schmaier
The Kinin System 1997
Curcumin inhibits the proliferation and cell cycle progression of human umbilical vein endothelial cell
AK Singh, GS Sidhu, T Deepa, RK Maheshwari
Cancer Letters 1996
Effects of antirheumatic agents on cytokines
P Barrera, AM Boerbooms, LB van de Putte, JW van der Meer
Seminars in Arthritis and Rheumatism 1996
Bufalin inhibits endothelial cell proliferation and angiogenesis in vitro
DY Lee, M Yasuda, T Yamamoto, T Yoshida, Y Kuroiwa
Life Sciences 1996
Molecular biology of dissemination in bladder cancer ? laboratory findings and clinical significance
BJ Schmitz-Drger, F Jankevicius, R Ackermann
World Journal of Urology 1996
Copper Chelation Inhibits Tumor Angiogenesis in the Experimental 9L Gliosarcoma Model
D Yoshida, Y Ikeda, S Nakazawa
Neurosurgery 1995
Endothelial cells in culture: a model to study in vitro vascular toxicity
O Chappey, MP Wautier, JL Wautier
Toxicology in Vitro 1995
The effect of auranofin and sulphasalazine therapy on circulating levels of interleukin 6 in rheumatoid arthritis patients
A Crilly, HA Capell, J Watson, R Madhok
Clinical Rheumatology 1995
Tumour vasculature--a potential therapeutic target
CT Baillie, MC Winslet, NJ Bradley
British Journal of Cancer 1995
A novel angiogenesis inhibitor suppresses rat adjuvant arthritis
DJ Peacock, ML Banquerigo, E Brahn
Cellular Immunology 1995
Advances in Drug Research
CL Crespi
Advances in Drug Research 1995
Copper Chelation Inhibits Tumor Angiogenesis in the Experimental 9L Gliosarcoma Model:
D Yoshida, Y Ikeda, S Nakazawa
Neurosurgery 1995
Antiangiogenesis as a novel therapeutic concept in pediatric oncology
L Schweigerer
Journal of Molecular Medicine 1995
Inhibition of neovascularization in vivo by gold compounds
R Saura, T Matsubara, K Mizuno
Rheumatology International 1994
Inhibition of Tumor Angiogenesis
EP Sipos, RJ Tamargo, JD Weingart, H Brem
Annals of the New York Academy of Sciences 1994
Angiogenesis inhibition: A review
W Auerbach, R Auerbach
Pharmacology & Therapeutics 1994
Inhibition of inflammatory angiogenesis in rats by loco-regional administration of hydrocortisone and protamine
D Foschi, L Castoldi, F Corsi, E Radaelli, E Trabucchi
Agents and Actions 1994
Does improved control of tumour growth require an anti-cancer therapy targeting both neoplastic and intratumoral endothelial cells?
G Gasparini, AL Harris
European Journal of Cancer 1994
Assay of the antiangiogenic compound TNP-470, and one of its metabolites, AGM-1883, by reversed-phase high-performance liquid chromatography in plasma
WD Figg, HJ Yeh, A Thibault, JM Pluda, F Itoh, R Yarchoan, MR Cooper
Journal of Chromatography B Biomedical Sciences and Applications 1994
Inhibition of mitogen-induced response of human peripheral blood mononuclear cells by bucillamine, a new antirheumatic sulfhydryl drug
T Akamatsu, T Matsubara, Y Saegusa, K Mizuno
Rheumatology International 1994
Endothelial proliferation in experimental granulomatous colitis: Autoradiography and immunohistochemistry studies
N Pooley, L Ghosh, J Blanchard, P Sharon
Digestive Diseases and Sciences 1994
Suppression of 9L gliosarcoma growth by copper depletion with copper-deficient diet and D-Penicillamine
D Yoshida, Y Ikeda, S Nakazawa
Journal of Neuro-Oncology 1993
Anti-angiogenesis: a multipurpose therapeutic tool?
D Ribatti, A Vacca, M Bertossi, L Roncali
International Journal of Clinical & Laboratory Research 1993
Cutaneous malignant melanoma
SJ Hoffman, JJ Yohn, DA Norris, CM Smith, WA Robinson
Current Problems in Dermatology 1993
Formation of DNA strand breaks by D-penicillamine and bucillamine in human lymphocytes
H Yamanaka, M Hakoda, N Kamatani, S Kashiwazaki, DA Carson
Immunopharmacology 1993
Humoral Factors in the Regulation of Tissue Growth
PP Foà
1993
Oncogenes and Tumor Suppressor Genes in Human Malignancies
CC Benz, ET Liu
1993
Ionic regulation of human basophil releasability. I. Inhibitory effect of copper
A Tedeschi, M Arquati, M Lorini, N Milazzo, A Miadonna
Agents and Actions 1992
Angiogenesis and angiogenesis inhibitors in paediatric diseases
L Schweigerer, T Fotsis
European Journal of Pediatrics 1992
Angiogenesis inhibition suppresses collagen arthritis
DJ Peacock, ML Banquerigo, E Brahn
Journal of Experimental Medicine 1992
Short-term dietary copper deficiency does not inhibit angiogenesis in tumours implanted in striated muscle
DA Schuschke, MW Reed, JT Saari, MD Olson, DM Ackermann, FN Miller
British Journal of Cancer 1992
Effects of nicardipine on tube formation of bovine vascular endothelial cells in vitro
T Kaneko, I Nagata, S Miyamoto, H Kubo, H Kikuchi, T Fujisato, Y Ikada
Stroke; a journal of cerebral circulation 1992
Emoxypine as an inhibitor of angiogenesis
AA Sologub, SI Akberova, GG Ziangirova
Bulletin of Experimental Biology and Medicine 1992
Angiogenesis and rheumatoid arthritis: pathogenic and therapeutic implications
PR Colville-Nash, DL Scott
Annals of the rheumatic diseases 1992
Exercise induced release of von Willebrand factor: evidence for hypoxic reperfusion microvascular injury in rheumatoid arthritis
AJ Farrell, RB Williams, CR Stevens, AS Lawrie, NL Cox, DR Blake
Annals of the rheumatic diseases 1992
Eicosapentaenoic acid inhibits tube formation of vascular endothelial cellsin vitro
T Kanayasu, I Morita, J Nakao-Hayashi, N Asuwa, C Fujisawa, T Ishii, H Ito, S Murota
Lipids 1991
Effects of lobenzarit disodium on human endothelial cells. Lobenzarit disodium inhibits proliferative response, HLA–DR antigen expression, and T cell adherence toward endothelial cells
A Kawakami, K Eguchi, Y Ueki, K Migita, H Ida, H Nakao, A Kurata, T Fukuda, S Nagataki, T Ishimaru, K Kurouji, N Fujita
Arthritis & Rheumatism 1991
Novel growth regulatory factors and tumour angiogenesis
R Bicknell, AL Harris
European Journal of Cancer and Clinical Oncology 1991
Inhibition of angiogenesis and tumor growth in the brain. Suppression of endothelial cell turnover by penicillamine and the depletion of copper, an angiogenic cofactor
SS Brem, D Zagzag, AM Tsanaclis, S Gately, MP Elkouby, SE Brien
The American Journal of Pathology 1990
How to Characterize a Biological Antioxidant
B Halliwell
Free Radical Research 1990
Development of angiogenesis inhibitors for clinical applications
TE Maione, RJ Sharpe
Trends in Pharmacological Sciences 1990
d-Penicillamine
DA Joyce
Baillière's Clinical Rheumatology 1990
The heat shock protein response and its role in inflammatory disease
VR Winrow, L McLean, CJ Morris, DR Blake
Annals of the rheumatic diseases 1990
CuSO4 as an Inhibitor of B Cell Proliferation
T YAMAUCHI, I YAMAMOTO
The Japanese Journal of Pharmacology 1990
Correspondence
I Chanarin, L Szur
British Journal of Haematology 1975

← Previous 1 2 3 4 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 12 patents
12 readers on Mendeley
See more details